180 related articles for article (PubMed ID: 3118674)
21. Normal and abnormal pituitary glands: gadopentetate dimeglumine-enhanced MR imaging.
Sakamoto Y; Takahashi M; Korogi Y; Bussaka H; Ushio Y
Radiology; 1991 Feb; 178(2):441-5. PubMed ID: 1987606
[TBL] [Abstract][Full Text] [Related]
22. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
23. Sensitivity of Gd-DTPA-enhanced MR imaging of benign extraaxial tumors.
Haughton VM; Rimm AA; Czervionke LF; Breger RK; Fisher ME; Papke RA; Hendrix LE; Strother CM; Turski PA; Williams AL
Radiology; 1988 Mar; 166(3):829-33. PubMed ID: 3340779
[TBL] [Abstract][Full Text] [Related]
24. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
[TBL] [Abstract][Full Text] [Related]
25. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
Low RN; Francis IR
AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
[TBL] [Abstract][Full Text] [Related]
26. MR imaging of pituitary hypertrophy due to juvenile primary hypothyroidism: a case report.
Kuroiwa T; Okabe Y; Hasuo K; Yasumori K; Mizushima A; Masuda K
Clin Imaging; 1991; 15(3):202-5. PubMed ID: 1933650
[TBL] [Abstract][Full Text] [Related]
27. ACTH secreting pituitary microadenomas disclosed only by gadolinium DTPA enhanced MRI.
Boleaga B; Fanghänel G; Cortinas L; Valdés E; Vargas E; Velasco F
Rev Invest Clin; 1993; 45(1):37-42. PubMed ID: 8387223
[TBL] [Abstract][Full Text] [Related]
28. Rathke cleft cysts: correlation of enhanced MR and surgical findings.
Sumida M; Uozumi T; Mukada K; Arita K; Kurisu K; Eguchi K
AJNR Am J Neuroradiol; 1994 Mar; 15(3):525-32. PubMed ID: 8197952
[TBL] [Abstract][Full Text] [Related]
29. Sequential MR enhancement pattern in normal pituitary gland and in pituitary adenoma.
Yuh WT; Fisher DJ; Nguyen HD; Tali ET; Gao F; Simonson TM; Schlechte JA
AJNR Am J Neuroradiol; 1994 Jan; 15(1):101-8. PubMed ID: 8141039
[TBL] [Abstract][Full Text] [Related]
30. Varied microcirculation of pituitary adenomas at rapid, dynamic, contrast-enhanced MR imaging.
Finelli DA; Kaufman B
Radiology; 1993 Oct; 189(1):205-10. PubMed ID: 8372195
[TBL] [Abstract][Full Text] [Related]
31. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population.
Hall WA; Luciano MG; Doppman JL; Patronas NJ; Oldfield EH
Ann Intern Med; 1994 May; 120(10):817-20. PubMed ID: 8154641
[TBL] [Abstract][Full Text] [Related]
32. MR imaging of pituitary region lesions with gadodiamide injection.
Hald JK; Skalpe IO; Bakke SJ; Nakstad PH
Acta Radiol; 1994 Jan; 35(1):65-9. PubMed ID: 8305277
[TBL] [Abstract][Full Text] [Related]
33. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT.
Low RN; Barone RM; Lacey C; Sigeti JS; Alzate GD; Sebrechts CP
Radiology; 1997 Aug; 204(2):513-20. PubMed ID: 9240546
[TBL] [Abstract][Full Text] [Related]
34. Gadolinium-enhanced MR imaging in the management of a midline cerebral dysgerminoma.
Hawes DR; Yuh WT; Wen BC
Comput Med Imaging Graph; 1989; 13(6):463-8. PubMed ID: 2598155
[TBL] [Abstract][Full Text] [Related]
35. [Role of gadolinium (Gd-DTPA) in the staging of renal carcinoma using magnetic resonance. Comparative evaluation with computerized tomography and magnetic resonance without contrast media].
De Cobelli F; Vanzulli A; Colombo E; Bonato C; Sironi S; Del Maschio A
Radiol Med; 1993 May; 85(5):562-9. PubMed ID: 8327756
[TBL] [Abstract][Full Text] [Related]
36. Gd-DTPA-enhanced MR imaging of the brain in patients with meningitis: comparison with CT.
Chang KH; Han MH; Roh JK; Kim IO; Han MC; Kim CW
AJNR Am J Neuroradiol; 1990; 11(1):69-76. PubMed ID: 2105619
[TBL] [Abstract][Full Text] [Related]
37. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
[TBL] [Abstract][Full Text] [Related]
38. Dyke award. Gd-DTPA-enhanced MR imaging of experimental bacterial meningitis: evaluation and comparison with CT.
Mathews VP; Kuharik MA; Edwards MK; D'Amour PG; Azzarelli B; Dreesen RG
AJR Am J Roentgenol; 1989 Jan; 152(1):131-6. PubMed ID: 2783267
[TBL] [Abstract][Full Text] [Related]
39. Bladder tumor staging: comparison of conventional and gadolinium-enhanced dynamic MR imaging and CT.
Tanimoto A; Yuasa Y; Imai Y; Izutsu M; Hiramatsu K; Tachibana M; Tazaki H
Radiology; 1992 Dec; 185(3):741-7. PubMed ID: 1438756
[TBL] [Abstract][Full Text] [Related]
40. Effect of dose and field strength on enhancement with paramagnetic contrast media.
Lindsey RO; Yetkin FZ; Prost R; Haughton VM
AJNR Am J Neuroradiol; 1994 Nov; 15(10):1849-52. PubMed ID: 7863934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
